Skip to content
Screener

Regeneron Pharmaceuticals REGN Ratios & Valuation

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
Profitability
Operating margin24.7%-2.3pp24.3%-2.9pp24.9%-3.2pp25.9%-2.8pp27%-1.9pp
Net margin27.9%-3.5pp29.6%-2.3pp31.4%+0.3pp32.1%-1.5pp31.4%-0.7pp
Returns
Return on equity14%-1.3pp14.5%-1.4pp14.9%-1.1pp15.2%-2.0pp15.3%-1.2pp
Return on invested capital10.3%-1.5pp10.3%-2.0pp10.1%-3.1pp10.7%-2.7pp11.8%-1.9pp
Efficiency
Asset turnover0.4×0.0×0.4×0.0×0.4×0.0×0.4×0.0×0.4×0.0×
Liquidity
Current ratio3.3×-1.3×3.6×-1.4×4.1×-0.6×4.1×-1.2×4.6×-0.8×
Leverage
Debt-to-equity0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Net debt / EBITDA0.1×-0.1×-0.1×0.0×-0×-0.1×0×-0.1×0.2×0.0×
Per Share
Book value per share$299.16+8.5%$291.77+10.4%$287.82+12.9%$288.79+14.4%$275.68+12.8%
Valuation
Market capitalization$78.52B+29.6%$81.68B+17.8%$81.12B+3.6%$59.59B-47.6%$56.39B-50.2%
Price / earnings18.1×+4.6×18.5×+3.1×18×+0.3×13×-11.4×12.6×-13.6×
Price / sales5.1×+0.8×5.5×+0.6×5.7×+0.1×4.2×-4.0×4×-4.4×
Price / book2.5×+0.5×2.6×+0.2×2.6×-0.1×1.9×-2.0×1.9×-2.1×
EV / EBITDA18×+3.9×19.5×+3.6×19.6×+2.0×14.2×-11.5×13.1×-13.1×
Dividend yield0.5%+0.2pp0.5%+0.3pp0.5%—0.5%—0.3%—

FAQ

What are Regeneron Pharmaceuticals's profit margins?
Regeneron Pharmaceuticals (REGN) runs a 94.9% gross margin and a 24.7% operating margin, with a 27.9% net margin.
Where do Regeneron Pharmaceuticals's ratios come from?
Every ratio is computed from Regeneron Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.